Status:
RECRUITING
Non-disabling Ischemic Cerebrovascular Event With Apathy
Lead Sponsor:
Changhai Hospital
Conditions:
Apathy
Minor Stroke
Eligibility:
All Genders
18-80 years
Brief Summary
The burden of non-disabling ischemic cerebrovascular events (NICE) is significantly increased. However, few previous studies have focused on affective impairment after transient ischemic attack (TIA) ...
Detailed Description
Transient ischemic attack (TIA) and acute minor ischemic stroke, are common and may leave impermanent or mild neurological deficit, they are termed as non-disabling ischemic cerebrovascular disease (N...
Eligibility Criteria
Inclusion
- ≥18 years old Onset of a minor stroke (National Institute of Health stroke scale, NIHSS≤3) and TIA elapsed time from last episode to registry \<1 month
Exclusion
- patients who refused to participate in the research, and patients who failed to complete the follow-up protocol.
- patients with malignant tumors, or patients with severe liver or kidney disease, whose life expectancy is less than 1 year.
- patients who received endovascular or thrombolytic therapy.
Key Trial Info
Start Date :
July 10 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 10 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04917237
Start Date
July 10 2021
End Date
June 10 2024
Last Update
February 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433